GEN - Genetic Engineering and Biotechnology News2d
AI Could Revolutionize Biopharma Process Validation
While AI adoption in GMP settings is still evolving, regulatory agencies emphasize explainability and validation of AI models ...
Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma
Q4 2024 Management View CEO Jennifer Ernst highlighted significant advancements, including the acquisition of exclusive worldwide rights to the Phase III immunomodulatory drug candidate Entolimod, ...
Business Wire10d
LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids, and Suppositories
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...